EUVIMEDObjevte EUVIMED
Crossref

Association of VEGFA Polymorphisms with Proliferative Diabetic Retinopathy in Iraqi T2DM Patients: A Case–Control Study with Adjusted Models and Functional VEGF Levels

Hamza J. Jabour, Hussein A. Jamil, Nebrass F. Chachain, Estabraq M. Ati

Israa University Journal for Applied Science · 2026

DOI: 10.52865/ectv6080 ↗

At a glance

Journal article in Israa University Journal for Applied Science, 2026. Written by Hamza J. Jabour and 3 co-authors.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Diabetic retinopathy is a complication of type 2 diabetes mellitus and arises due to vascular endothelial growth factor-A (VEGF-A), which promotes pathological retinal angiogenesis.

Objective

To evaluate the association of VEGF single nucleotide polymorphisms with predisposition to proliferative diabetic retinopathy. Methodology: The study was conducted at Najaf Teaching Hospital, Iraq, from April 2023 to February 2024, and included 120 participants divided into three groups. Serum VEGF-A levels were measured to ascertain the genotype of two VEGF-A SNPs, rs6921438 and rs955772463. Results: the result show a progressive rise in VEGF-A across all the groups: mean value of 145 ± 35 pg/mL for the control group, 220 ± 50 pg/mL for the type 2 diabetic group without malignant diabetic retinopathy, and 310 ± 70 pg/mL for the type 2 diabetic group with malignant diabetic retinopathy. VEGF-A showed a positive increase with glycated hemoglobin (HbA1c), duration of diabetes, and body mass index (BMI); this may infer that poor glycemic control, long-standing diabetes, and high BMI are all associated with enhanced retinal angiogenesis. Regression analysis thus showed that single nucleotide polymorphisms were an independent predictor of malignant diabetic retinopathy.

Conclusions

VEGF-A represents a robust biomarker for the development of diabetic retinopathy, reflecting the activity of retinal angiogenesis independently of traditional clinical risk factors. Maintaining good blood glucose and weight control is essential for reducing vascular endothelial growth factor-A (VEGF-A) activity and slowing the progression of malignant diabetic retinopathy.

Cite

APA

Jabour, H. J., Jamil, H. A., Chachain, N. F., & Ati, E. M. (2026). Association of VEGFA Polymorphisms with Proliferative Diabetic Retinopathy in Iraqi T2DM Patients: A Case–Control Study with Adjusted Models and Functional VEGF Levels. Israa University Journal for Applied Science. https://doi.org/10.52865/ectv6080

Vancouver

Jabour HJ, Jamil HA, Chachain NF, Ati EM. Association of VEGFA Polymorphisms with Proliferative Diabetic Retinopathy in Iraqi T2DM Patients: A Case–Control Study with Adjusted Models and Functional VEGF Levels. Israa University Journal for Applied Science. 2026. doi:10.52865/ectv6080

BibTeX
@article{Jabour2026,
  author = {Jabour, Hamza J. and Jamil, Hussein A. and Chachain, Nebrass F. and Ati, Estabraq M.},
  title = {Association of VEGFA Polymorphisms with Proliferative Diabetic Retinopathy in Iraqi T2DM Patients: A Case–Control Study with Adjusted Models and Functional VEGF Levels},
  journal = {Israa University Journal for Applied Science},
  year = {2026},
  doi = {10.52865/ectv6080}
}
Start for free →